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Immunoassays are nowadays a crucial tool for diagnostics and drug development.  However 
they often involve time-consuming procedures and need at least two antibodies in charge of 
the capture and detection processes respectively. We report a nanocomposite based on 
graphene oxide-coated nanopaper (GONAP) facilitating an advantageous immunosensing 
platform using a single antibody and without the need for washing steps. The hydrophilic, 
porous and photoluminescence-quenching character of GONAP allows for the adsorption and 
quenching of photoluminescent quantum dots nanocrystals complexed with antibodies (Ab-
QDs), enabling a ready-to-use immunosensing platform. The photoluminescence is recovered 
upon immunocomplex (antibody-antigen) formation which embraces a series of interactions 
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(hydrogen bonding, electrostatic, hydrophobic and Van der Waals interactions) that trigger 
desorption of the antigen-Ab-QD complex from GONAP surface. However, the antigen is 
then attached onto the GONAP surface by electrostatic interactions leading to a spacer 
(greater than c.a. 20 nm) between Ab-QDs and GONAP and thus hindering non-radiative 
energy transfer. We demonstrate that this simple -yet highly sensitive- platform represents a 
virtually universal immunosensing approach by using small-sized and big-sized targets as 
model analytes, those are, human-IgG protein and Escherichia coli bacteria. In addition, the 
assay was proved effective in real matrices analysis, including human serum, poultry meat 
and river water. GONAP opens the way to conceptually new paper-based devices for 
immunosensing, which are amenable to point of care applications and automated diagnostics. 
 
1. Introduction 
 
Immunoassays capitalize on the selectivity and sensitivity of antibody-antigen interactions so 
as to capture and detect analytes in biological or environmental samples.[1] Being highly 
specific techniques, immunoassays are the most extensively used detection approaches for the 
analytical determination of clinically relevant biomarkers.[2,3] They are also important drug 
screening platforms and prominent proteomic tools.[4,5] Consequently, they are a corner-stone 
in diagnostics and biological research. In fact, there are different configurations (direct, 
indirect, sandwich, competitive) and various technologies exploiting immunoassays such as 
microarray, lateral flow and enzyme-linked immunosorbent assay.[1]   Nevertheless, they often 
require time-consuming labors (e.g. multiple washing steps) and/or at least two antibodies in 
charge of the capture and detection of the analyte, respectively. In addition, most of them are 
not particularly easy-to-use or amenable to portability.[6] Given this paucity, the technological 
and scientific community is actively working on the development of cost-efficient and simple 
approaches facilitating innovative immunosensing approaches.[7–15]  
We have previously reported bacterial cellulose nanopaper as an advantageous biosensing 
platform since it offers a myriad of outstanding properties,[16,17] including environmental 
sustainability, biodegradability, excellent chemical-modification capabilities (so as to be 
functionalized), optical transparency and several other physicochemical properties (low 
density, hydrophilicity, high porosity, high flexibility, high surface area and high 
crystallinity).[18,19]  Moreover, we have been studying the interaction between photoexcited 
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quantum dots and graphene oxide (GO), offering innovative approaches in biosensing based 
on non-radiative energy transfer, which is highly efficient due to the high surface area and 
excellent photoluminescence-quenching nature exhibited by GO,[20] even when compared 
with other carbon forms.[21]  Herein, we engineered a hydrophilic, porous and 
photoluminescence-quenching nanohybrid material made of graphene oxide-coated nanopaper 
(GONAP). Although the optical properties of GO have been exploited in several 
immunosensing systems, they often require both, a capture antibody and a detection 
antibody.[22,23] GONAP represents an advantageous immunosensing platform that uses a 
single antibody and requires no-washing steps. This nanocomposite facilitates adsorption and 
quenching of photoluminecent quantum dots nanocrystals conjugated with antibodies (Ab-
QDs), allowing a ready-to-use immunosensing platform. As the immunocomplex creation 
involves hydrogen bonding, electrostatic, hydrophobic and Van der Waals interactions, the 
complex antigen-Ab-QDs undergoes a desorption from GONAP surface upon 
immunocomplex formation and the photoluminescence is then recovered given that the 
antigen is anchored onto the GONAP surface by electrostatic, π– π stacking and hydrogen 
bonding interactions. Specifically, given the moieties of GO,  such as hydroxyl and carboxyl 
groups, and the hydroxyl groups of nanopaper, hydrogen bonding between GONAP and 
hydroxyl and amino groups presents in the analytes (or Ab-QDs) is also able to occur. These 
phenomena lead to a spacer (greater than c.a. 20 nm) between Ab-QDs and GONAP, which 
avoids highly efficient non-radiative energy transfer. Thus, the fluorescence recovery is 
proportional to the analyte concentration. The operational concept of this immunosensing 
platform is depicted in Figure 1. To demonstrate that this immunosensing platform is 
technically sound for small-sized and big-sized targets detection, we employed human-IgG 
protein and Escherichia coli (E. coli) bacteria as model analytes, respectively. Additionally, 
we performed a series of assays in real matrices such as human serum, poultry meat and river 
water to prove the potential effectiveness of the approach in real sample analysis. 
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2. GONAP biosensing platform 
Bacterial cellulose nanopaper (BC, a film of nanocellulose) synthesized by Acetobacter 
xylinum was employed in the proposed immunosensing platform. BC has been previously 
characterized in terms of average fiber diameter (c.a. 45 ± 10 nm), fiber length (>10 μm), 
crystallinity (∼82%), crystallite size (∼6.3 nm), average tensile strength (∼345 MPa), 
Young’s modulus (∼17.3 GPa) and strain-at-break (∼7%).[16] A water-based dispersion of 
single layer GO sheets with average lateral dimension range of ∼500 nm and C/O ratio about 
one unit (supplier’s data) was exploited to build the GONAP nanocomposite. As BC exhibits 
hydroxyl groups onto the surface and GO also has hydroxyl groups onto the basal plane, they 
can be easily coupled via hydrogen bonding (see experimental section). Streptavidin-
decorated CdSe@ZnS QDs with an average size ∼14 ± 2 nm and a maximum emission 
wavelength at ∼665 nm were employed as photoluminecent agent in the proposed 
immunosensing platform. Scanning electron microscopy micrographs of bare BC, GONAP 
and Ab-QDs-GONAP are shown in Figure 2, respectively. 
Various concentrations of GO decorating BC were evaluated and compared with bare BC in 
order to select the most efficient photoluminescence-quenching concentration judiciously. 
Herein, 150 μg mL-1 of GO in milliQ water was selected as the optimum concentration and 
the most appropriate for the immunosensing platform (see supplementary Figure S1 and S2 in 
the supporting information), which achieved the maximum quenching efficiency (around 
50%) when compared with bare BC. Additionally,  the concentration of QDs and anti-E. coli 
antibody and the incubation time for the immunoreaction were carefully selected based on the 
most sensitive response, taking the analysis of the blank sample as reference. It was found that 
the optimum concentrations of QDs and Ab are 100 nM and 0.9 mg mL-1, respectively. 
Consequently, [GO] ≈ 150 μg mL−1, [QDs] ≈ 100 nM and [anti-E. coli Ab] ≈ 0.9 mg mL-1 
were employed for sensitive detection of foodborne pathogen (E. coli O157:H7). Moreover, 
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the optimum incubation time was 30 min for capturing the target bacteria by the specific Ab. 
The same aforementioned optimization procedures were carried out for protein detection, 
whereas the optimum concentrations were ca. 100 μg mL−1, 100 nM, and 0.2 mg mL-1 for GO, 
QDs and anti-human IgG Ab, respectively for protein detection, while an optimum incubation 
period of 2 h was found the most appropriate for protein detection (see supplementary Figure 
S5). It is well known that the suitable incubation time for any immunoreaction strongly 
depends on the analyte size,[24] thus there is a significant difference between E. coli and 
protein detection in this parameter (E. coli size ≈ 0.5×1.5-2 μm, human IgG size ≈  12 nm). 
Although the size of these analytes is completely different, the biosensing mechanism is 
driven by the same aforementioned principle that eventually leads to a spacer between 
photoexcited QDs and GONAP (greater than c.a. 20 nm), hindering a highly efficient non-
radiative energy transfer phenomenon. Thus, the proposed biosensing system is able to detect 
both small-sized and big-sized analytes as demonstrated below. 
 
2.1. GONAP for pathogen detection 
 
The performance of the proposed immunosensing platform as a pathogen detection device 
was evaluated by using ten-fold serial concentrations of E. coli O157:H7 (10 to 106 CFU 
mL−1) in a standard buffer. Blank sample (buffer containing zero bacteria) was studied to 
distinguish between the presence and the absence of the target analyte. The 
photoluminescence intensity ratios (F1/F0) of the test and the blank spots were estimated in 
dimensionless units by dividing the final photoluminescence intensity (F1) into the initial 
photoluminescence intensity (F0) of the same GONAP spot, which determine the presence or 
absence of the target pathogen. Furthermore, the F1/F0 ratio allows for the measurement of 
tiny amounts of the analyte circumventing analytical problems due to the original intensity of 
F0, which can be considered the background signal. Given the operational concept of the 
immunosensing platform, the photoluminescence of the test spots is expected to increase upon 
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addition of the pathogen, whereas that of the blank spots is expected to be relatively constant 
or decrease slightly due to the removal of the excess of some Ab-QD complexes after the 
contact with the liquid sample. Figure 3a shows how the F1/F0 ratio of the analyzed blank 
sample was around 0.8, while serial dilutions of E. coli obtained a F1/F0 ratio greater than this 
value. The proposed immunosensing platform showed a highly sensitive response to the 
presence of the target bacteria with a wide detection range, from 10 to 106 CFU mL-1, where 
the F1/F0 ratio increased gradually with E. coli concentration at the range from 10 to 105 CFU 
mL-1 with a full saturation of the system at 106 CFU mL-1. As experimental evidences, Figure 
3b shows images of the photoluminescent performance of GONAP immunosensing platform 
targeting E. coli. and Figure 3c displays a SEM micrograph of the platform after adding the 
target bacteria. Moreover, from that logarithmic response, the estimated detection limit of E. 
coli in standard buffer was about 55 CFU mL−1, which has been calculated by the mean value 
F1/F0 ratio of the blank plus 3 times its standard deviation, see Supplementary Figure 10A 
(threshold line).   
 
In order to investigate the effect of washing steps on GONAP immunosensing platform, a 
series of assays was carried out via GONAP immunosensing platform and washing steps were 
performed using 100 μL of PBST followed by 100 μL milli-Q water. After discarding the 
washing solution, a fluctuating response in the F1/F0 ratio with serial E. coli concentrations 
has been observed. This could be attributed to the weak attaching forces between GONAP and 
the complex antigen-Ab-QDs.[25] This fluctuating response is shown in supplementary Figure 
S4. Importantly, we discovered that the overall optimal performance of the proposed 
immnosensing platform does not require washing steps.  
 
2.1.1. GONAP specificity in pathogen detection 
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We also explored the specificity of GONAP immunosensing platform targeting E. coli in the 
presence of another non-target bacterial strain form the same “Enterobacteriaceae family”. 
Salmonella typhimurium was selected as a non-specific pathogen for conducting this 
experiment. Different concentrations of the target and non-target bacteria were simultaneously 
analyzed in standard buffer in order to assess the specificity of the developed assay as 
follows; a) blank standard buffer, b) low concentration of E. coli (102 CFU mL-1), c) high 
concentration of E. coli (105 CFU mL−1), d) high concentration of S. typhimurium (105 CFU 
mL-1), e) a mixture of high concentration of E. coli  (105 CFU mL-1) and low concentration of 
S. typhimurium (102 CFU mL-1) and f) a mixture of high concentration of S. typhimurium (105 
CFU mL-1) and low concentration of E. coli (102 CFU mL-1). It was found, as illustrated in 
Figure 3d, that the F1/F0 ratio of the non-target pathogen (S. typhimurium) even at high 
concentration was below the threshold of the limit of detection limit (LOD) and very similar 
to blank one. Additionally, the presence of the non-target pathogen in the same media with the 
target one (E. coli) does not affect the response of the immunoassay; since the response 
produced by a mixture of [E. coli (102 CFU mL-1) + S. typhimurium (105 CFU mL-1)] was 
very similar to that of E. coli (102 CFU mL-1) alone, likewise, the response of a mixture [E. 
coli (105 CFU mL-1) + S. typhimurium (102 CFU mL-1)] was very close to that of E. coli (105 
CFU mL-1) alone. These results indicate the high specificity and selectivity of the developed 
immunoassay even in the presence of other competing non-specific bacteria.  
2.1.2. GONAP for pathogen detection in real samples 
Although the application of any developed assay in buffer solution is very important for 
optimization, the analysis in real samples with minimal sample preparation is crucial in 
emergent biosensing platforms.[7] Therefore, serial concentrations of E. coli O157:H7 were 
inoculated in poultry meat and river water to be assayed by the proposed GONAP-based 
pathogen detection platform. Blank solutions of both poultry meat extract and river water 
were used as a negative control in this experiment. As shown in Supplementary Figure S5, 
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the F1/F0 ratios of the blank solutions of poultry meat extract and river water were around 0.7 
and 0.8, respectively. While the presence of the target bacteria increases the F1/F0 ratio to 
higher values. The obtained results illustrated in Supplementary Figure S5A-B show that the 
proposed pathogen detection platform has a highly sensitive response to the presence of E. 
coli in complex matrices of poultry meat and river water at wide detection ranges accounted 
for 50 to 1.5×105 CFU g-1 and 50 to 105 CFU mL-1, respectively. Whereas, the F1/F0 ratios 
raised gradually with increasing bacterial concentrations with logarithmic responses at the 
ranges 50 to 1.5×104 CFU g-1 and 50 to 104 CFU mL-1 in poultry meat and river water, 
respectively (Supplementary Figure S5). From these logarithmic responses, it was estimated 
that the limit of detection of E. coli in poultry meat and river water are 65 and 70 CFU g or 
mL-1, respectively. These relatively low limits of detection in real samples without broth 
enrichment indicate the capability of E. coli detection in real food and water samples at levels 
< 1 CFU g-1 and 1 CFU mL-1 respectively after ca. 2 hours of broth incubation. Although 
there was a slight influence by the matrix of real samples due to the effect of the 
microenvironment changes (the local viscosity, pH, ionic strength, polarity and hydrogen-
bonding capability of the matrix) on the photoluminescence of QDs,[26] it does not affect the 
feasibility of the assay in real samples and confirms the possibility of using this novel 
immunoassay for pathogen detection in other complex real samples. As detailed in the 
Supporting Information, recovery tests were performed in order to investigate the accuracy 
and the performance of the developed immunoassay in complex matrices and standard buffer. 
These results confirming an acceptable accuracy level of the proposed system are shown in 
Table 1. 
 
2.2. GONAP for protein detection 
In addition, we explored the overall performance of GONAP immunosensing platform for the 
detection of a human protein. Human IgG has been employed as a model protein. Firstly, a 
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polyclonal anti-human IgG antibody (pAb) was used for the immunoassay. Several 
concentrations of human IgG ranging from 3.125 to 50 ng mL−1 in standard buffer were 
investigated (under optimized condition, supplementary Figure S3). As shown in 
supplementary Figure S9, the F1/F0 ratio of the blank buffer was around 0.9 units, while the 
presence of the target analyte (IgG) obtained greater values due to the aforementioned 
operational principle of the proposed immunosensing system. A detection range from 3.125 to 
25 ng mL-1 was obtained, (Supplementary Figure S9A). A scanned photo of GONAP before 
and after various amounts of IgG (from top and downward; 3.125, 6.25, 12.5 and 25 ng mL-1) 
presented that the photoluminescent intensity is correlational with the amount of protein, see 
Supplementary Figure S9B. From that logarithmic relation, a limit of detection accounted for 
1.91 ng mL-1 was obtained (Supplementary Figure S11a).  
To investigate whether this innovative immunoassay can only be accomplished by integrating 
polyclonal antibodies or not, a monoclonal antibody targeting human IgG (mAb) was also 
employed. Interestingly, it was found that GONAP immunosensing platform is also able to 
operate using monoclonal antibodies. In fact, mAb provided greater fluorescence intensities 
than those obtained using polyclonal antibodies when both were compared using human IgG 
concentration of 3.125 ng mL-1 (Supplementary Figure S11d). For human IgG detection using 
mAb, the detection range was 195 pg mL-1 to 3.125 ng mL-1 (Figure 4a), and provided a 
lower limit of detection than that of pAb, accounted for 1.60 ng mL-1, as calculated from the 
logarithmic response in Supplementary Figure S11b.  Importantly, pAb are expected to 
perform a sandwich-like immunocomplex due to its ability to bind multiple sites of the 
antigen, whereas mAb cannot perform a sandwich-like configuration due to its ability to bind 
a single site of the antigen. Hence, these results suggest both, that the complex antigen-Ab-
QD is likely to be anchored by the antigen side and that GONAP is also able to anchor 
sandwich-like immunocomplexes (supplementary Figure S6), enforcing the virtually 
universal operational principle of GONAP immunosensing platform. Moreover, scanning 
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electron microcopy revealed that mAb promotes a higher population density of complexes 
antigen-Ab-QD upon analyte addition (Figure 4d) when compared to that promoted by using 
pAb (Figure 4c). This observation clarifies the high sensitivity obtained by using mAb. 
The selectivity study of the proposed GONAP-based immunoassay for protein detection was 
also investigated in the presence of non-specific immunoglobulin type and using pAb (it 
should be remarked that polyclonal antibodies are often less specific than monoclonal 
antibodies). These experiments are described in the Supporting Information, whose results 
indicate the high specificity of the developed immunoassay using pAb even in the presence of 
other competing non-specific type of immunoglobulin (supplementary Figure S7). Likewise, 
we successfully explored the efficiency of the protein sensing platform in complex matrixes 
by screening different concentrations of human IgG (HIgG) in human serum (supplementary 
Figure S8).  
 
2.2.1. GONAP for protein detection in real samples 
Moreover, in order to compare the performance of the developed immunoassay in real 
samples and standard buffer, spike and recovery tests were done using human 
immunoglobulin-depleted serum as a real matrix. Three concentrations of human IgG within 
the respective detection range were spiked in human immunoglobulin depleted serum samples, 
and then the recovery percentages from human serum were estimated and compared with 
those of standard buffer. It was found that the recoveries of human IgG from human serum 
ranged from 93 to 98%, as listed in Table 2. These recovery percentages indicate that the 
complex matrix of human serum does not affect the reliability of the proposed immunoassay 
and confirm the possibility of its application in real sample analysis.  
 
3. Conclusion 
Taking advantage of the hydrophilic, porous and photoluminescence-quenching character of 
GONAP, we developed an advantageous and highly transformative immunosensing platform 
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requiring no-washing steps and exploiting a single antibody. The immonosensing mechanism 
is triggered by an immunoreaction leading to both, desorption of previously anchored Ab-
QDs and attachment of the complex antigen-Ab-QD. This configures a spacer (> ~20 nm) 
between GONAP and the Ab-QDs, disrupting highly efficient non-radiative energy transfer. 
Fast (30 min), highly sensitive and selective detection and quantification of a pathogen (E. 
coli) have been recorded at limits of detection accounted for ca. 55, 65 and 70 CFU mL-1 or g-
1 in standard buffer, poultry meat and river water, respectively, without previous broth 
enrichment. This result indicates the ability to detect < 1 CFU mL-1 or g-1 of E. coli after ca. 2 
hours of sample-broth enrichment. Moreover, the proposed device showed a quick (120 min) 
and sensitive detection of human protein at a detection limit of for 1.60 ng mL-1. In addition, 
this innovative immunosensing platform is able to show an acceptable level of accuracy 
(recovery values between 93 and 98%). Although the specificity and sensitivity (in terms of 
percentage of false  positive/negatives, respectively) of this approach has not been determined 
in the present stage of this research, the successful application of this immunoassay in real 
matrices analysis opens up innovative capabilities in food, environmental and biological 
samples analysis. Additionally, this paper-based platform is easy-to-use, cost-effective, and 
suitable for portability, point of care applications, automated devices, and multi-analyte 
detection as well. 
 
4. Experimental Section  
All commercial reagents were of analytical grade and handled according to the material safety 
data sheets suggested by the suppliers. Bacterial cellulose nanopaper (BC) was purchased 
from Nanonovin Polymer Co. (Mazandaran, Iran). Graphene oxide (GO) was purchased from 
Angstron Materials (Dayton, OH, U.S.A.). Poly-L-lysine coated glass slides (Cat.No. 22247-
1) were purchased from Polysciences Europe GmbH (Hirschberg an der Bergstrasse, 
Germany). Anti-Escherichia coli antibody (biotin) (pAb, ab68451), sheep anti-human IgG 
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H&L (biotin) and Mouse monoclonal H2 anti-human IgG Fc (biotin) (mAb, ab99766) were 
obtained from Abcam (Cambridge, U.K.), and streptavidin-quantum dot 655 was from Life 
Technologies (Carlsbad, CA, USA). Phosphate buffered saline (PBS) tablet (P4417), bovine 
serum albumin (BSA), and Tween-20 were purchased from Sigma-Aldrich (Madrid, Spain). 
Escherichia coli O157:H7 (CECT 4783, E. coli) and Salmonella enterica subsp. enterica 
serovar typhimurium LT2 (CECT 722T, S. typhimurium) strains were obtained from the 
Colección Española de Cultivos Tipo (CECT, Valencia, Spain). IgG and IgA from human 
serum were purchased from Sigma-Aldrich (Madrid, Spain). Human immunoglobulin IgG/ 
IgA/ IgM/ IgE depleted serum was purchased from Celprogen (Torrance, CA, USA).  PBS 
(10 mM, pH 7.4) with 0.5% (v/v) Tween-20 containing 1% of BSA fraction V (w/v) was 
employed as standard buffer. All aqueous solutions were freshly prepared in ultrapure water 
produced using a Milli-Q system (>18.2 MΩcm−1) purchased from Millipore. TS-100 
Thermo-Shaker (Biosan, Riga, Latvia) was used as the stirrer for modification of QDs with 
antibodies. An AlphaScanTM 3.0 microarray scanner (San Leandro, CA, USA) was used to 
record the photoluminescence images on GONAP surface. A JP Selecta 2000210 oven (JP 
Selecta s.a., Barcelona, Spain) was used for drying graphene oxide nanocomposites. Scanning 
electron microscopy (SEM) was performed through a Magellan 400L SEM High Resolution 
SEM (FEI, Hillsboro, OR, USA).   
Synthesis of GONAP. GO was integrated into the BC nanonetwork via hydrogen bonding by 
taking advantage of the presence of hydroxyl groups exhibited by both BC and GO. To this 
end, nine pieces of previously sterilized wet BC (approx. size 0.25×0.25×0.1 cm3) were 
washed in 100 mL of hot milliQ water at 60°C for 30 min under vigorous stirring. 
Consequently, the water was discarded and 100 mL of graphene oxide suspension (150 μg 
mL-1) was added to the cellulose nanopaper (see detailed optimization procedure of GO 
concentration in the supplementary material) and incubated at 90°C for 2 h with vigorous 
stirring. After that, GONAP was separated from the GO suspension and washed 5 times with 
  
13 
 
milliQ water, which removes unbound GO and ensures a homogeneous distribution of  the 
GO embedded in BC. Finally, the composites were kept to dry in a hot air oven at 50°C for 30 
min.  The color change of BC from colorless to dark brown confirms the synthesis of GONAP. 
Then, the dried composites were kept at room temperature under dark conditions before being 
used in the immunoassay. SEM was used to characterize and confirm the successful synthesis 
of the composite. 
Conjugation of QDs with antibodies (Ab). For pathogen detection, QDs were mixed with anti-
E.coli Ab in a standard buffer to form final concentrations of 100 nM for QDs and 900 μg 
mL−1 for Ab. While for protein detection, QDs were mixed with anti-human IgG Ab in the 
standard buffer to reach final concentrations of 100 nM for QDs and 200 μg mL−1 for Ab. 
Subsequently, the conjugation process was carried out by continuous shaking at 650 rpm, and 
4°C for 30 min (see detailed optimization procedure of QDs concentration and the 
conjugation process in the Supporting Information, Figures S1, S2 and S3). 
Bacterial Strains and Inocula Preparation. Freeze-dried cultures of E. coli O157:H7 and 
Salmonella typhimurium were revived in Tryptone Soy Broth (TSB, Oxoid Ltd., UK) and 
incubated for 24 h at 37ºC, then transferred onto Tryptone Soy Agar plates (TSA, Oxoid Ltd., 
UK). Stock cultures of both strains were prepared on Tryptone Soy Agar slopes for future use. 
Afterwards, bacterial cell suspensions were prepared directly in sterile PBST and river water, 
using bacterial colonies from the plates, during the logarithmic phase, to obtain a bacterial 
load of 1.5 x 108 CFU mL-1 according to McFarland standards [27]  using Densimat 
densitometer (Biomerieux, Brazil). Subsequently, ten-fold decimal bacterial dilutions (10 to 
108 CFU mL-1) were prepared from the original one. Finally, heat killing of the inocula was 
performed by placing the inoculated tubes in a water bath at 90ºC for 15 min to stop bacterial 
replication. While in case of poultry meat, a tube of heat-killed bacteria (1.5 x 108 CFU mL-1) 
in sterile PBST was used to prepare ten-fold decimal dilutions in poultry extract. The prepared 
inocula were stored at 4 °C until being used. 
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Preparation of poultry meat extract: chicken meat fillets were obtained from a local retail 
market in Barcelona and analyzed by standard culturing method for the presence of E. coli [28], 
and only negative samples were selected to be inoculated with bacteria. Twenty-five grams of 
E. coli-free poultry meat were homogenized with 225 mL of sterile PBS in a sterile bag using 
a stomacher (Lab Blender 400, Seward, UK) for 3 min. Then the homogenate was clariﬁed by 
filtration using Whatman filter paper, grade 41 (pore size: 20-25 µm) to remove large 
particles, and finally the filtrate was used as a diluent for preparation of different bacterial 
inocula. 
Preparation of GONAP immunosensing platform. A punching tool was used to cut the dried 
GO-BC composites into small rounded spots (Diameter ≈ 0.6 cm), and then these spots were 
placed onto a poly-L-lysine slide. Consequently, 1.5 μL of the previously prepared QDs-Ab 
conjugate was dropped on each GONAP spot, and left to dry at room temperature. The initial 
photoluminescence intensity (F0) of these spots was measured using a microarray scanner. A 
silicone gasket was used per each slide to separate each spot/assay. 
Using GONAP immunosensing platform for E. coli detection in a standard buffer. 100 μL of 
each dilution of the previously prepared suspensions of E. coli O157:H7 in standard buffer 
(10 to 106 CFU mL−1) was pipetted onto each spot of GONAP immunosensing platform, 
which were placed on the poly-L-lysine slide masked with silicone gasket. In parallel, control 
spots were prepared using standard buffer free of E. coli. Three parallel experiments 
analyzing the same sample were carried out to ensure repeatability. Then the mixture was 
incubated at room temperature for 30 min. Afterward, bacterial suspensions were discarded 
and the test and control spots were left to dry at room temperature before reading the final 
intensity of the photoluminescence (F1) using the microarray scanner. ImageJ 1.50i (Wayne 
Rasband, National Institutes of Health, Maryland, USA) was used to analyze both initial and 
final photoluminescence intensities to calculate the intensity ratio (F1/F0). Limit of detection 
(LOD) of the developed immunoassay was estimated by calculating the average F1/F0 of 
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blank samples plus three times the standard deviation. The specificity of the assay was 
evaluated using Salmonella typhimurium as non-specific bacteria (separately and in the 
presence of E. coli O157:H7). 
Validating GONAP immunosensing platform for E. coli detection in real matrices. The 
performance of the developed immunosensing platform in bacteria detection was evaluated in 
complex matrices using poultry meat and river water as model samples. The same 
aforementioned procedure carried out for E. coli inoculated in standard buffer was applied for 
previously prepared ten-fold serial concentrations of E. coli O157:H7 inocula in poultry meat 
and river water; however, the concentration of QDs was increased to 120 nM in case of river 
water. LOD in real samples was estimated by the same above mentioned method in standard 
buffer. 
To assure whether the performance is affected by the difference between the buffer used to 
prepare the standard curve and the real sample matrix or not, spike and recovery experiment 
was conducted to assess the precision of the developed immunosensing platform in complex 
sample types. This experiment was conducted by spiking 102, 103 and 104 CFU mL-1 or g of 
E .coli O157:H7 in standard buffer, poultry meat and river water (three replicates for each 
bacterial concentration in each sample) and the recovery percentages of the bacteria from real 
samples (poultry meat and river water) were calculated as comparing with the standard buffer.  
Using GONAP immunosensing platform for protein detection in standard buffer. The 
aforementioned procedure of E. coli detection was adapted in case of protein (human IgG) 
detection. Briefly, human IgG was prepared at different concentrations in the standard buffer 
(3.125 to 100 ng mL-1) and stored in the fridge at 4°C until use. 100 μL of the analyte 
suspensions were added on the previously prepared spots of GONAP immunosensing 
platform for human IgG. After incubation for 2 h at room temperature, the analyte suspension 
was discarded and the spots were left to dry at room temperature before reading the final 
photoluminescence intensity using a microarray scanner. Afterwards, the analysis of the 
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images and calculation of the LOD of IgG were done by the same above-mentioned methods 
used in E. coli detection. The specificity of the assay was evaluated using human IgA as a 
non-target protein (separately and in a mixture with human IgG). 
Validating GONAP immunosensing platform for protein detection in human serum. The 
performance of the developed immunosensing platform for protein detection was evaluated in 
complex real matrices using human immunoglobulin-depleted serum as a real matrix. The 
same aforementioned procedure carried out with human IgG inoculated in standard buffer was 
conducted for various concentrations of human IgG (7 to 700 ng mL-1) in human 
immunoglobulin-depleted serum. The LOD of Human IgG in human serum was estimated by 
the same abovementioned method in E. coli detection. Similar to E. coli detection procedures, 
a spike and recovery test was conducted for IgG by spiking 6.25, 12.5 and 25 ng mL-1 of IgG 
in both standard buffer and human immunoglobulin-depleted serum (at least 3 replicates for 
each protein concentration) and the recovery percentages of protein from human serum were 
calculated as comparing with standard buffer.  
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Figure 1. Operational concept of the immunosening approach (schematic representation, not 
to scale). The hydrophilic, porous and photoluminescence-quenching character of GONAP 
allows for the adsorption and quenching of Ab-QDs, whereas photoluminescence recovery is 
triggered by the immunocomplex formation phenomenon, which involves a series of forces 
and interactions detaching the antigen-Ab-QD complex. Nevertheless, the antigen is then 
attached onto GONAP surface working as spacer between GONAP and Ab-QDs and 
hindering highly efficient non-radiative energy transfer. The immunosensing platform can be 
turned “On” by either big-sized analytes (pathogens) or small-sized analytes (proteins). 
 
 
Figure 2.  Scanning-electron micrographs of GONAP platform. a. Bare bacterial cellulose 
nanopaper. b. GONAP. c. Ab-QDs on GONAP. 
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Figure 3. GONAP immunosensing platform for pathogen detection. a. Overall performance 
of E. coli detection in standard buffer. b. Photoluminescence images of GONAP 
immunosensing platform (before and after adding different concentrations of pathogen). c. 
Scanning-electron micrographs of E. coli captured by GONAP immunosensing platform. d. 
Study of the specificity of GONAP immunosensing platform targeting a model pathogen (E 
coli, E.c) in the presence of a non-target pathogen (S. typhimurium, S.). The threshold in red 
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(a, d) represents the limit of detection of the proposed device, which was estimated as the 
mean value of the blank samples plus three times their standard deviation. The error bars 
represent the standard deviation of at least three replicates.  
 
 
 
Figure 4. GONAP immunosensing platform for protein detection. a. Photoluminescent 
response for protein detection in standard buffer using monnoclonal anti-human IgG antibody 
(mAb). b. Experimental evidence (scanned photo) of the photoluminescent intensity on 
GONAP before and after adding different concentrations of protein. c. Scanning-electron 
micrograph of human IgG at a concentration of 25 ng mL−1 in standard buffer. The target is 
  
21 
 
captured by the protein sensing platform using a polyclonal antibody. d. Scanning-electron 
micrographs of human IgG at a concentration of 3.12 ng mL−1 in standard buffer. The target is 
captured by the protein sensing platform using a monoclonal antibody.  
 
 
 
Table 1. Spike and recovery assay results.  
Real samples Spiked bacteria  
[CFU mL-1  
or CFU g-1] 
F1/F0
a) 
in standard buffer 
F1/F0
b) 
in real matrices 
 
Recovery % 
Poultry meat  102 1.145 1.118 97.60 
103 1.205 1.184 98.30 
104 1.396 1.305 93.47 
River water 102 1.101 1.061 96.35 
103 1.231 1.201 97.60 
104 1.359 1.323 97.30 
a) Performed in standard buffer; b) performed in real matrices. The experiment was done by 
spiking 102, 103 and 104 CFU mL-1 of E. coli in standard buffer, poultry meat and river water 
(n=3 for each sample), and the recovery percentages of bacteria from real samples were 
estimated by comparing with standard buffer. 
 
 
Table 2. Spike and recovery assay results in human immunoglobulin (IgG/ IgA/ IgM/ IgE) 
depleted serum 
Spiked protein 
(ng mL-1) 
F1/F0
a) 
 
F1/F0
b) 
 
Recovery % 
6.25 (pAb) 1.30 1.23 94.35 
12.5 (pAb) 1.41 1.36 96.76 
25 (pAb) 1.62 1.59 98.46 
0.39 (mAb) 1.08 1.01 93.75 
0.78 (mAb) 1.18 1.10 93.08 
1.56 (mAb) 1.29 1.27 98.66 
a) Performed in standard buffer; b) performed in human serum samples.  The experiment was 
done by spiking 6.25, 12.5 and 25 ng mL-1 of HIgG in standard buffer and human 
immunoglobulin IgG/ IgA/ IgM/ IgE depleted serum (n=9 for each sample), and the recovery 
percentages of protein from human serum depleted immunoglobulin samples were estimated 
by comparing with standard buffer. (pAb) Performed using a polyclonal antibody. (mAb) 
Performed using a monoclonal antibody. 
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Graphene oxide-coated nanopaper is introduced as an immunosensing platform, this 
virtually universal immunoassay approach avoids washing steps and facilitates rapid analysis 
without compromising its sensitivity. 
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